Is Flo Health profitable in 2026?

No public profitability figures have been disclosed. Flo raised $200M+ in a July 2024 Series C from General Atlantic at a $1B+ valuation and reported nearly 5M paid subscribers as of mid 2024, but the company has not confirmed net profit or loss in any public statement.

Could AI replace Flo Health?

Generic cycle-math and symptom Q&A can be approximated by chatbots like ChatGPT or Gemini, but Flo's decade-long proprietary dataset from 80M+ users, used in its own AI prediction models and Mayo Clinic research since 2026, is not something an AI assistant can replicate.

Is Flo Health being sued over privacy?

Yes. Flo and Google agreed to a combined $56M settlement over health-data sharing, with Flo's share about $8M and a final court approval hearing set for October 29, 2026. A separate British Columbia class action was certified in March 2024 and remains pending.

Flo Health is privately held, founded in 2015 by brothers Dmitry and Yuri Gurski, with Dmitry serving as CEO. Its largest known investor is General Atlantic, which led a $200M+ Series C in July 2024 that pushed the valuation past $1 billion.

Who is Flo Health's biggest competitor?

Apple has shipped free OS-level cycle tracking in iOS Health since 2019, a persistent bundling threat. Direct femtech rivals include Clue and Natural Cycles, the latter claiming its users are twice as satisfied as Flo's in its own vendor marketing.

Did Flo Health raise a new funding round recently?

Flo's most recent disclosed raise was $200M+ in a Series C led by General Atlantic, announced July 30, 2024, valuing the company above $1 billion and making it, per the company, Europe's first femtech unicorn. No new round has been publicly confirmed since.

Consumer platforms · United States

Flo Health

flo.health ↗

App that tracks periods, ovulation, and fertility for roughly 80 million users.

Defensible for now

Assessed 23 July 2026 · Evidence as of 23 July 2026

Real protection, with named pressure against it.

On the recordSince 23 July 2026 · Checkable from October 29, 2026 · Every call on the record Checkpoint: Final approval hearing for the $56M Google/Flo privacy settlement

The call

Flo keeps growing on the strength of habit and years of stored personal data, while privacy lawsuits and Apple's free tracking sit in the background as ongoing costs rather than immediate stoppers.

Flo makes a smartphone app that helps women track their menstrual cycles and related health. It is hard for competitors to replace because Flo has collected ten years of personal cycle data from millions of users, which makes the app smarter and more personalized over time, and users trust it with sensitive information. Apple added free cycle tracking to its phones in 2019 but Flo kept growing, showing users value the specialized features. The real threats are Apple expanding into perimenopause tracking and winning users away, and a privacy lawsuit that must get final approval in October 2026, which could damage Flo's reputation and force costly changes if the settlement is large.

Why

AI pressure: ChatGPT and Gemini answering cycle and symptom questions directly. Chatbots can answer generic cycle questions for free, but they don't hold a person's years of logged health data like Flo does. Could AI do the core job? Unlikely.

Bigger players: Apple Health cycle tracking, built into iPhone since 2019. Apple already gives away free cycle tracking on every iPhone, and Flo still grew to 80 million users despite it. Could a giant copy it? Probably.

What protects it. Years of personal cycle history stored in Flo make switching to a new app feel like starting over.

What would change this call

Outcome of Oct 29, 2026 final approval hearing for the $56M Google-Flo privacy settlement. Shows whether privacy litigation risk is closing out or extending further.
Apple or Google announcing perimenopause or clinician-grade women's health features at WWDC or Google I/O. Would show OS-level platforms encroaching on Flo's core content category.
Flo headcount and burn-rate trend in FY2026 filings or press coverage. Would show whether the flat-to-declining staffing reflects efficiency or slowing growth.

Key numbers

80M+ monthly active users (mid-2026)
696 employees, Growth Score 14/100 (Jul 2026)
$56M privacy settlement, Flo pays ~$8M (Oct 2025)

Named risks

Ongoing privacy class actions including $56M Google-Flo settlement, final hearing Oct 29 2026. Severity: high
Apple or Google could deepen free OS-level perimenopause/fertility features, eroding differentiation. Severity: medium
Flat to slightly declining headcount (625 to 696 range) signals cost discipline or growth stall post-Series C. Severity: medium
Only ~0.3% global femtech market share despite category-leader status, in a fragmented field. Severity: medium
Generic educational content layer commoditized by free LLM chatbots. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Apple	contesting	Free OS-level cycle tracking shipped in iOS Health since June 2019, still coexists with Flo's growth
Natural Cycles	contesting	Claims 2x user satisfaction vs Flo in own marketing, unverified vendor claim
Clue	contesting	Named co-leader of $4.36B women's digital health market alongside Flo, April 2026 report
ChatGPT/Gemini	contesting	Generic symptom Q&A and cycle math increasingly answerable by general AI chatbots as of 2026

Questions people ask

Is Flo Health profitable in 2026?: No public profitability figures have been disclosed. Flo raised $200M+ in a July 2024 Series C from General Atlantic at a $1B+ valuation and reported nearly 5M paid subscribers as of mid 2024, but the company has not confirmed net profit or loss in any public statement.
Could AI replace Flo Health?: Generic cycle-math and symptom Q&A can be approximated by chatbots like ChatGPT or Gemini, but Flo's decade-long proprietary dataset from 80M+ users, used in its own AI prediction models and Mayo Clinic research since 2026, is not something an AI assistant can replicate.
Is Flo Health being sued over privacy?: Yes. Flo and Google agreed to a combined $56M settlement over health-data sharing, with Flo's share about $8M and a final court approval hearing set for October 29, 2026. A separate British Columbia class action was certified in March 2024 and remains pending.
Who owns Flo Health?: Flo Health is privately held, founded in 2015 by brothers Dmitry and Yuri Gurski, with Dmitry serving as CEO. Its largest known investor is General Atlantic, which led a $200M+ Series C in July 2024 that pushed the valuation past $1 billion.
Who is Flo Health's biggest competitor?: Apple has shipped free OS-level cycle tracking in iOS Health since 2019, a persistent bundling threat. Direct femtech rivals include Clue and Natural Cycles, the latter claiming its users are twice as satisfied as Flo's in its own vendor marketing.
Did Flo Health raise a new funding round recently?: Flo's most recent disclosed raise was $200M+ in a Series C led by General Atlantic, announced July 30, 2024, valuing the company above $1 billion and making it, per the company, Europe's first femtech unicorn. No new round has been publicly confirmed since.

Timeline

2026-07-13Flo and Mayo Clinic publish study on social determinants of perimenopause symptoms
2026-05-12Flo expands doctor-backed perimenopause tools for Premium users
2026-01-28Flo Health and Mayo Clinic publish first global perimenopause awareness study
2025-10-03$56M Google-Flo privacy settlement announced; Flo's share about $8M
2025-08-01Meta found liable by jury for CIPA violations tied to Flo data-sharing
2025-07-17Flo for Perimenopause feature launches to all users
2025-01-21Flo appoints cybersecurity leaders to privacy and security advisory board
2024-07-30Flo raises $200M+ Series C from General Atlantic at $1B+ valuation
2024-03-01British Columbia class action against Flo certified
2021-09-01Flo raises $50M Series B at $800M valuation

Revision history

23 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Discord Naver Corporation ByteDance